-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In order to do a good job in the implementation of the ICH guidelines, our center has drafted the ICH "E14 and Q&A: Non-antiarrhythmic drugs-induced QT/QTc interval prolongation and potential arrhythmogenic effects of clinical evaluation and Q&A documents" and "Q3C (R8) ): Impurities: Residual Solvents" Guiding Principles Transformation and Implementation Suggestions are now open for comments
.
Please send relevant opinions to our center by e-mail before December 2, 2021: gkzhqyj@cde.
org.
cn
E14 and Q&A and Q3C (R8) guidelines can be found on the ICH website
.
(Https://
Attachment: ICH E14 and Q&A and Q3C (R8) Guiding Principles Transformation and Implementation Suggestions
Drug Evaluation Center of the State Drug Administration
November 2 2021
Relevant attachments: 1ICH E14 and Q&A and Q3C (R8) Guiding Principles Implementation Suggestions.
1ICH E14 and Q&A and Q3C (R8) guidelines implementation recommendations.
docx